

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 8.55825641 |
| 2 | cardiac myofibril assembly (GO:0055003) | 8.04421620 |
| 3 | tricarboxylic acid cycle (GO:0006099) | 7.64907405 |
| 4 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.63774686 |
| 5 | myofibril assembly (GO:0030239) | 7.31796665 |
| 6 | actin-myosin filament sliding (GO:0033275) | 7.04912540 |
| 7 | muscle filament sliding (GO:0030049) | 7.04912540 |
| 8 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.87487246 |
| 9 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 6.46469262 |
| 10 | cardiac muscle contraction (GO:0060048) | 6.33994182 |
| 11 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.22178441 |
| 12 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.21203370 |
| 13 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.17226324 |
| 14 | cardiac muscle cell development (GO:0055013) | 5.97546519 |
| 15 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.87955305 |
| 16 | actin-mediated cell contraction (GO:0070252) | 5.86740596 |
| 17 | regulation of skeletal muscle contraction (GO:0014819) | 5.78676654 |
| 18 | plasma membrane repair (GO:0001778) | 5.77207540 |
| 19 | regulation of relaxation of muscle (GO:1901077) | 5.69141103 |
| 20 | regulation of actin filament-based movement (GO:1903115) | 5.63663370 |
| 21 | cardiac cell development (GO:0055006) | 5.60594294 |
| 22 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.45258483 |
| 23 | actomyosin structure organization (GO:0031032) | 5.40715993 |
| 24 | regulation of cofactor metabolic process (GO:0051193) | 5.38543014 |
| 25 | regulation of coenzyme metabolic process (GO:0051196) | 5.38543014 |
| 26 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.30065040 |
| 27 | * carnitine shuttle (GO:0006853) | 5.29630486 |
| 28 | adult heart development (GO:0007512) | 5.26119219 |
| 29 | cardiac muscle hypertrophy (GO:0003300) | 5.21337260 |
| 30 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.18061162 |
| 31 | striated muscle contraction (GO:0006941) | 5.12392455 |
| 32 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.10317518 |
| 33 | regulation of sequestering of triglyceride (GO:0010889) | 5.04308264 |
| 34 | regulation of sarcomere organization (GO:0060297) | 5.01704502 |
| 35 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.00833922 |
| 36 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.00333211 |
| 37 | striated muscle hypertrophy (GO:0014897) | 4.96584936 |
| 38 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.89490559 |
| 39 | NADH metabolic process (GO:0006734) | 4.87291066 |
| 40 | heart trabecula formation (GO:0060347) | 4.85439697 |
| 41 | response to inactivity (GO:0014854) | 4.78384481 |
| 42 | muscle tissue morphogenesis (GO:0060415) | 4.76817945 |
| 43 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.76178345 |
| 44 | * fatty acid transmembrane transport (GO:1902001) | 4.67307256 |
| 45 | regulation of striated muscle contraction (GO:0006942) | 4.63130468 |
| 46 | heart process (GO:0003015) | 4.61561052 |
| 47 | heart contraction (GO:0060047) | 4.61561052 |
| 48 | regulation of cell communication by electrical coupling (GO:0010649) | 4.57870985 |
| 49 | actin filament-based movement (GO:0030048) | 4.39902215 |
| 50 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.39777413 |
| 51 | regulation of the force of heart contraction (GO:0002026) | 4.37937728 |
| 52 | muscle hypertrophy (GO:0014896) | 4.37791221 |
| 53 | regulation of sulfur metabolic process (GO:0042762) | 4.35038729 |
| 54 | regulation of fatty acid oxidation (GO:0046320) | 4.27616781 |
| 55 | regulation of membrane repolarization (GO:0060306) | 4.26128823 |
| 56 | cell communication involved in cardiac conduction (GO:0086065) | 4.22630302 |
| 57 | * carnitine transmembrane transport (GO:1902603) | 4.22531849 |
| 58 | 2-oxoglutarate metabolic process (GO:0006103) | 4.12598808 |
| 59 | skeletal muscle adaptation (GO:0043501) | 4.10296099 |
| 60 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.08987261 |
| 61 | oxidative phosphorylation (GO:0006119) | 4.08676921 |
| 62 | respiratory electron transport chain (GO:0022904) | 4.04849918 |
| 63 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.00760192 |
| 64 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.97360119 |
| 65 | electron transport chain (GO:0022900) | 3.93702643 |
| 66 | * amino-acid betaine transport (GO:0015838) | 3.89964745 |
| 67 | * carnitine transport (GO:0015879) | 3.89964745 |
| 68 | * fatty acid beta-oxidation (GO:0006635) | 3.89846548 |
| 69 | regulation of cardiac muscle contraction (GO:0055117) | 3.80327879 |
| 70 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.76473027 |
| 71 | response to muscle activity (GO:0014850) | 3.76461586 |
| 72 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.75785766 |
| 73 | muscle hypertrophy in response to stress (GO:0003299) | 3.75785766 |
| 74 | cardiac muscle adaptation (GO:0014887) | 3.75785766 |
| 75 | cell communication by electrical coupling (GO:0010644) | 3.75009297 |
| 76 | creatine metabolic process (GO:0006600) | 3.72558131 |
| 77 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.71648008 |
| 78 | ATP synthesis coupled proton transport (GO:0015986) | 3.71648008 |
| 79 | succinate metabolic process (GO:0006105) | 3.71533741 |
| 80 | aspartate family amino acid catabolic process (GO:0009068) | 3.71505598 |
| 81 | negative regulation of necroptotic process (GO:0060546) | 3.69821513 |
| 82 | negative regulation of potassium ion transport (GO:0043267) | 3.67891452 |
| 83 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.63968804 |
| 84 | regulation of heart rate (GO:0002027) | 3.63766984 |
| 85 | lysine metabolic process (GO:0006553) | 3.63135979 |
| 86 | lysine catabolic process (GO:0006554) | 3.63135979 |
| 87 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.61198773 |
| 88 | cardiac muscle cell action potential (GO:0086001) | 3.59719293 |
| 89 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.59053085 |
| 90 | relaxation of cardiac muscle (GO:0055119) | 3.54320962 |
| 91 | skeletal muscle contraction (GO:0003009) | 3.49755373 |
| 92 | muscle adaptation (GO:0043500) | 3.48462111 |
| 93 | regulation of ATPase activity (GO:0043462) | 3.44970402 |
| 94 | regulation of ATP catabolic process (GO:1903289) | 3.44970402 |
| 95 | striated muscle cell development (GO:0055002) | 3.43796863 |
| 96 | negative regulation of necrotic cell death (GO:0060547) | 3.43451052 |
| 97 | negative regulation of protein localization to cell surface (GO:2000009) | 3.43295568 |
| 98 | muscle contraction (GO:0006936) | 3.42009450 |
| 99 | tricarboxylic acid metabolic process (GO:0072350) | 3.40723393 |
| 100 | regulation of cardioblast differentiation (GO:0051890) | 3.37785387 |
| 101 | regulation of heart contraction (GO:0008016) | 3.33953834 |
| 102 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.33871304 |
| 103 | regulation of necroptotic process (GO:0060544) | 3.31123179 |
| 104 | ventricular cardiac muscle cell development (GO:0055015) | 3.29693700 |
| 105 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.25614996 |
| 106 | striated muscle atrophy (GO:0014891) | 3.24163573 |
| 107 | biotin metabolic process (GO:0006768) | 3.23688026 |
| 108 | striated muscle adaptation (GO:0014888) | 3.22345101 |
| 109 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.20392108 |
| 110 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.20392108 |
| 111 | muscle system process (GO:0003012) | 3.20247941 |
| 112 | positive regulation of myotube differentiation (GO:0010831) | 3.15640188 |
| 113 | glycogen catabolic process (GO:0005980) | 3.10720173 |
| 114 | germinal center formation (GO:0002467) | 3.07969326 |
| 115 | mitochondrial genome maintenance (GO:0000002) | 3.03552688 |
| 116 | cardiac ventricle formation (GO:0003211) | 2.99905275 |
| 117 | cellular response to epinephrine stimulus (GO:0071872) | 2.98463652 |
| 118 | glucan catabolic process (GO:0009251) | 2.98191923 |
| 119 | cardiac chamber formation (GO:0003207) | 2.98148327 |
| 120 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.96053189 |
| 121 | mannose metabolic process (GO:0006013) | 2.95367843 |
| 122 | positive regulation of cation channel activity (GO:2001259) | 2.84188181 |
| 123 | response to epinephrine (GO:0071871) | 2.82553338 |
| 124 | cellular polysaccharide catabolic process (GO:0044247) | 2.80913454 |
| 125 | negative regulation of myotube differentiation (GO:0010832) | 2.80780013 |
| 126 | regulation of muscle contraction (GO:0006937) | 2.79202115 |
| 127 | negative regulation of cell size (GO:0045792) | 2.78734350 |
| 128 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.77203080 |
| 129 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.76588006 |
| 130 | negative regulation of cell killing (GO:0031342) | 2.76588006 |
| 131 | skeletal muscle fiber development (GO:0048741) | 2.75152692 |
| 132 | histone H3-K9 demethylation (GO:0033169) | 2.74461695 |
| 133 | muscle atrophy (GO:0014889) | 2.72853597 |
| 134 | regulation of gamma-delta T cell activation (GO:0046643) | 2.72785081 |
| 135 | muscle fiber development (GO:0048747) | 2.72064470 |
| 136 | regulation of muscle system process (GO:0090257) | 2.72010365 |
| 137 | activation of protein kinase A activity (GO:0034199) | 2.71633006 |
| 138 | regulation of ARF GTPase activity (GO:0032312) | 2.69337238 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.69213688 |
| 2 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.82009125 |
| 3 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.62057249 |
| 4 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.43389514 |
| 5 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.96105273 |
| 6 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.96105273 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.42795912 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.24359921 |
| 9 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.92603897 |
| 10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.62300610 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.55692256 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.45450115 |
| 13 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.39964810 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.38701653 |
| 15 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.23189457 |
| 16 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.22713232 |
| 17 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.21402681 |
| 18 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.21334595 |
| 19 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.15452323 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 2.09924984 |
| 21 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.09344717 |
| 22 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 2.06987660 |
| 23 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.04717385 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.04138501 |
| 25 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.03008161 |
| 26 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.87161415 |
| 27 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.86419459 |
| 28 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.83158139 |
| 29 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.73482818 |
| 30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.73413573 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.71392947 |
| 32 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.70911229 |
| 33 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.68982209 |
| 34 | KDM2B_26808549_Chip-Seq_K562_Human | 1.66871947 |
| 35 | MAF_26560356_Chip-Seq_TH1_Human | 1.65010348 |
| 36 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.64865189 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.64663466 |
| 38 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.62332437 |
| 39 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.60153309 |
| 40 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.58029192 |
| 41 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.56219128 |
| 42 | * MAF_26560356_Chip-Seq_TH2_Human | 1.54402900 |
| 43 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.51430513 |
| 44 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.51416222 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.50329912 |
| 46 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.48546370 |
| 47 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.48315275 |
| 48 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.46976406 |
| 49 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.46852745 |
| 50 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.43588559 |
| 51 | UTX_26944678_Chip-Seq_JUKART_Human | 1.40694446 |
| 52 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.39388251 |
| 53 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.39305691 |
| 54 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37524247 |
| 55 | SPI1_23127762_ChIP-Seq_K562_Human | 1.35503525 |
| 56 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.33849938 |
| 57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33630961 |
| 58 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32337868 |
| 59 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.32090491 |
| 60 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.31928183 |
| 61 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.31508751 |
| 62 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30961144 |
| 63 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.30306954 |
| 64 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.29017316 |
| 65 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27904955 |
| 66 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.24473438 |
| 67 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.24293968 |
| 68 | SA1_27219007_Chip-Seq_Bcells_Human | 1.22320552 |
| 69 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.19772522 |
| 70 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.18400651 |
| 71 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.18223286 |
| 72 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.18219160 |
| 73 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.18086755 |
| 74 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.17085022 |
| 75 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.16702876 |
| 76 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.16081397 |
| 77 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.14826527 |
| 78 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.12072359 |
| 79 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11544156 |
| 80 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.10865910 |
| 81 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08909443 |
| 82 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.07983511 |
| 83 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.07211383 |
| 84 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06122459 |
| 85 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.06114165 |
| 86 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05997140 |
| 87 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.05897466 |
| 88 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.05823350 |
| 89 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.05448798 |
| 90 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.05251332 |
| 91 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04968878 |
| 92 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.02861783 |
| 93 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.02261702 |
| 94 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.01108204 |
| 95 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.00660114 |
| 96 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.00422358 |
| 97 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.99717658 |
| 98 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.99450084 |
| 99 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98253031 |
| 100 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.98217594 |
| 101 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.97979726 |
| 102 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.97921819 |
| 103 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.96641145 |
| 104 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95767241 |
| 105 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.95235629 |
| 106 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.94118453 |
| 107 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.93927971 |
| 108 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92753098 |
| 109 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.92605913 |
| 110 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.91023657 |
| 111 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90902411 |
| 112 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.89766021 |
| 113 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89562876 |
| 114 | P68_20966046_ChIP-Seq_HELA_Human | 0.89011536 |
| 115 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88956503 |
| 116 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.88381729 |
| 117 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.88221380 |
| 118 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.88143912 |
| 119 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.88102381 |
| 120 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.87525383 |
| 121 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.86888088 |
| 122 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.86645623 |
| 123 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.84378228 |
| 124 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.81503325 |
| 125 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.81483320 |
| 126 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.81328748 |
| 127 | CJUN_26792858_Chip-Seq_BT549_Human | 0.80080201 |
| 128 | GATA2_19941826_ChIP-Seq_K562_Human | 0.79195159 |
| 129 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.78707105 |
| 130 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.78546722 |
| 131 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.78362149 |
| 132 | ATF3_27146783_Chip-Seq_COLON_Human | 0.76724060 |
| 133 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.76718173 |
| 134 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75669453 |
| 135 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75112765 |
| 136 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.74797072 |
| 137 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.74407035 |
| 138 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.74308359 |
| 139 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.73451363 |
| 140 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.72276944 |
| 141 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.72048525 |
| 142 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.71413073 |
| 143 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.70451897 |
| 144 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70395448 |
| 145 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.69105332 |
| 146 | GATA1_22025678_ChIP-Seq_K562_Human | 0.67481398 |
| 147 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.66936311 |
| 148 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.66635989 |
| 149 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.66141183 |
| 150 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.65674776 |
| 151 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.65605076 |
| 152 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65448539 |
| 153 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.64653872 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.55903316 |
| 2 | MP0003646_muscle_fatigue | 5.95878172 |
| 3 | MP0004084_abnormal_cardiac_muscle | 5.38258105 |
| 4 | MP0000751_myopathy | 4.99697931 |
| 5 | MP0004215_abnormal_myocardial_fiber | 4.44963245 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.17056160 |
| 7 | MP0000749_muscle_degeneration | 3.91409781 |
| 8 | MP0005330_cardiomyopathy | 3.85290018 |
| 9 | MP0004087_abnormal_muscle_fiber | 3.12241161 |
| 10 | MP0004130_abnormal_muscle_cell | 3.09739399 |
| 11 | MP0002972_abnormal_cardiac_muscle | 3.00570464 |
| 12 | MP0008775_abnormal_heart_ventricle | 2.87781830 |
| 13 | MP0005620_abnormal_muscle_contractility | 2.69861736 |
| 14 | MP0003137_abnormal_impulse_conducting | 2.66815870 |
| 15 | MP0000750_abnormal_muscle_regeneration | 2.62893636 |
| 16 | MP0002106_abnormal_muscle_physiology | 2.58259664 |
| 17 | MP0010630_abnormal_cardiac_muscle | 2.56683679 |
| 18 | MP0005385_cardiovascular_system_phenoty | 2.53108272 |
| 19 | MP0001544_abnormal_cardiovascular_syste | 2.53108272 |
| 20 | MP0004145_abnormal_muscle_electrophysio | 2.47635945 |
| 21 | MP0002269_muscular_atrophy | 2.36712799 |
| 22 | MP0006138_congestive_heart_failure | 2.32855631 |
| 23 | MP0005670_abnormal_white_adipose | 2.31320364 |
| 24 | MP0004484_altered_response_of | 2.30260216 |
| 25 | MP0005666_abnormal_adipose_tissue | 2.11810845 |
| 26 | MP0003828_pulmonary_edema | 2.09189556 |
| 27 | MP0005369_muscle_phenotype | 2.06324552 |
| 28 | MP0006036_abnormal_mitochondrial_physio | 2.05426968 |
| 29 | MP0000759_abnormal_skeletal_muscle | 2.04760064 |
| 30 | MP0000747_muscle_weakness | 2.03400348 |
| 31 | MP0004233_abnormal_muscle_weight | 2.01922342 |
| 32 | MP0003221_abnormal_cardiomyocyte_apopto | 2.01638105 |
| 33 | MP0004085_abnormal_heartbeat | 1.97697474 |
| 34 | MP0004510_myositis | 1.71704126 |
| 35 | MP0002332_abnormal_exercise_endurance | 1.62908579 |
| 36 | MP0002127_abnormal_cardiovascular_syste | 1.53550579 |
| 37 | MP0003950_abnormal_plasma_membrane | 1.51586203 |
| 38 | MP0004185_abnormal_adipocyte_glucose | 1.48265991 |
| 39 | MP0005375_adipose_tissue_phenotype | 1.37158889 |
| 40 | MP0002971_abnormal_brown_adipose | 1.20197293 |
| 41 | MP0003567_abnormal_fetal_cardiomyocyte | 1.16829022 |
| 42 | MP0003303_peritoneal_inflammation | 1.16160622 |
| 43 | MP0006035_abnormal_mitochondrial_morpho | 1.13880916 |
| 44 | MP0000343_altered_response_to | 1.13640949 |
| 45 | MP0000266_abnormal_heart_morphology | 1.13476694 |
| 46 | MP0004381_abnormal_hair_follicle | 1.08226241 |
| 47 | MP0003436_decreased_susceptibility_to | 1.05969047 |
| 48 | MP0002234_abnormal_pharynx_morphology | 1.04789690 |
| 49 | MP0010368_abnormal_lymphatic_system | 1.01329196 |
| 50 | MP0003279_aneurysm | 0.99643890 |
| 51 | MP0001790_abnormal_immune_system | 0.98508530 |
| 52 | MP0005387_immune_system_phenotype | 0.98508530 |
| 53 | MP0001800_abnormal_humoral_immune | 0.95462282 |
| 54 | MP0003763_abnormal_thymus_physiology | 0.93407912 |
| 55 | MP0003172_abnormal_lysosome_physiology | 0.93341759 |
| 56 | MP0009278_abnormal_bone_marrow | 0.90447104 |
| 57 | MP0005165_increased_susceptibility_to | 0.89388949 |
| 58 | MP0002108_abnormal_muscle_morphology | 0.88587661 |
| 59 | MP0005266_abnormal_metabolism | 0.88324821 |
| 60 | MP0008260_abnormal_autophagy | 0.87364404 |
| 61 | MP0005409_darkened_coat_color | 0.85607381 |
| 62 | MP0001835_abnormal_antigen_presentation | 0.85142296 |
| 63 | MP0003724_increased_susceptibility_to | 0.82949596 |
| 64 | MP0000230_abnormal_systemic_arterial | 0.79142459 |
| 65 | MP0000003_abnormal_adipose_tissue | 0.78717256 |
| 66 | MP0002933_joint_inflammation | 0.78653877 |
| 67 | MP0005623_abnormal_meninges_morphology | 0.76612604 |
| 68 | MP0003705_abnormal_hypodermis_morpholog | 0.75616998 |
| 69 | MP0000013_abnormal_adipose_tissue | 0.75066968 |
| 70 | MP0002128_abnormal_blood_circulation | 0.74196929 |
| 71 | MP0004043_abnormal_pH_regulation | 0.74058750 |
| 72 | MP0005410_abnormal_fertilization | 0.73676578 |
| 73 | MP0005451_abnormal_body_composition | 0.73561802 |
| 74 | MP0008569_lethality_at_weaning | 0.72580664 |
| 75 | MP0000685_abnormal_immune_system | 0.72459185 |
| 76 | MP0001661_extended_life_span | 0.71040302 |
| 77 | MP0005025_abnormal_response_to | 0.70369588 |
| 78 | MP0003879_abnormal_hair_cell | 0.69380216 |
| 79 | MP0001348_abnormal_lacrimal_gland | 0.68104932 |
| 80 | MP0003566_abnormal_cell_adhesion | 0.67576856 |
| 81 | MP0001879_abnormal_lymphatic_vessel | 0.67390685 |
| 82 | MP0002723_abnormal_immune_serum | 0.66182924 |
| 83 | MP0000733_abnormal_muscle_development | 0.65650743 |
| 84 | MP0002078_abnormal_glucose_homeostasis | 0.65590542 |
| 85 | MP0008961_abnormal_basal_metabolism | 0.63787031 |
| 86 | MP0008438_abnormal_cutaneous_collagen | 0.62222305 |
| 87 | MP0003806_abnormal_nucleotide_metabolis | 0.60629787 |
| 88 | MP0005000_abnormal_immune_tolerance | 0.59877232 |
| 89 | MP0002419_abnormal_innate_immunity | 0.58986802 |
| 90 | MP0002452_abnormal_antigen_presenting | 0.58202291 |
| 91 | MP0009115_abnormal_fat_cell | 0.57692958 |
| 92 | MP0005319_abnormal_enzyme/_coenzyme | 0.57213163 |
| 93 | MP0000678_abnormal_parathyroid_gland | 0.56831648 |
| 94 | MP0002420_abnormal_adaptive_immunity | 0.56652286 |
| 95 | MP0001819_abnormal_immune_cell | 0.55818397 |
| 96 | MP0005334_abnormal_fat_pad | 0.55780191 |
| 97 | MP0002138_abnormal_hepatobiliary_system | 0.55427788 |
| 98 | MP0001986_abnormal_taste_sensitivity | 0.55223770 |
| 99 | * MP0005535_abnormal_body_temperature | 0.53961628 |
| 100 | MP0008874_decreased_physiological_sensi | 0.53750429 |
| 101 | MP0004272_abnormal_basement_membrane | 0.53619891 |
| 102 | MP0001873_stomach_inflammation | 0.52902730 |
| 103 | MP0002132_abnormal_respiratory_system | 0.52845297 |
| 104 | MP0002822_catalepsy | 0.52058973 |
| 105 | MP0002118_abnormal_lipid_homeostasis | 0.51444394 |
| 106 | MP0005275_abnormal_skin_tensile | 0.51269623 |
| 107 | MP0002909_abnormal_adrenal_gland | 0.49392891 |
| 108 | MP0000767_abnormal_smooth_muscle | 0.48867639 |
| 109 | MP0002970_abnormal_white_adipose | 0.48676662 |
| 110 | MP0001849_ear_inflammation | 0.48155994 |
| 111 | MP0005671_abnormal_response_to | 0.47060581 |
| 112 | MP0000716_abnormal_immune_system | 0.45593392 |
| 113 | MP0002396_abnormal_hematopoietic_system | 0.44116515 |
| 114 | MP0003656_abnormal_erythrocyte_physiolo | 0.43858388 |
| 115 | MP0002398_abnormal_bone_marrow | 0.43289317 |
| 116 | MP0003948_abnormal_gas_homeostasis | 0.43119017 |
| 117 | MP0003984_embryonic_growth_retardation | 0.42296635 |
| 118 | MP0002925_abnormal_cardiovascular_devel | 0.41728507 |
| 119 | MP0005187_abnormal_penis_morphology | 0.41482779 |
| 120 | MP0002088_abnormal_embryonic_growth/wei | 0.40978214 |
| 121 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.40716981 |
| 122 | MP0005332_abnormal_amino_acid | 0.40147330 |
| 123 | MP0009785_altered_susceptibility_to | 0.39209413 |
| 124 | MP0002249_abnormal_larynx_morphology | 0.39071508 |
| 125 | MP0004147_increased_porphyrin_level | 0.38611577 |
| 126 | MP0005058_abnormal_lysosome_morphology | 0.37714181 |
| 127 | MP0005167_abnormal_blood-brain_barrier | 0.37578170 |
| 128 | MP0005452_abnormal_adipose_tissue | 0.36518346 |
| 129 | MP0001784_abnormal_fluid_regulation | 0.35150501 |
| 130 | MP0001614_abnormal_blood_vessel | 0.34926390 |
| 131 | MP0005448_abnormal_energy_balance | 0.30316217 |
| 132 | MP0003959_abnormal_lean_body | 0.29510881 |
| 133 | MP0009384_cardiac_valve_regurgitation | 0.28159721 |
| 134 | MP0001727_abnormal_embryo_implantation | 0.27938188 |
| 135 | MP0001853_heart_inflammation | 0.27135285 |
| 136 | MP0003045_fibrosis | 0.26877024 |
| 137 | MP0003195_calcinosis | 0.25912743 |
| 138 | MP0005595_abnormal_vascular_smooth | 0.24856482 |
| 139 | MP0001672_abnormal_embryogenesis/_devel | 0.22221001 |
| 140 | MP0005380_embryogenesis_phenotype | 0.22221001 |
| 141 | MP0005376_homeostasis/metabolism_phenot | 0.21169205 |
| 142 | MP0000249_abnormal_blood_vessel | 0.20116749 |
| 143 | MP0009840_abnormal_foam_cell | 0.18968563 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.69230230 |
| 2 | Exercise-induced myalgia (HP:0003738) | 6.41005967 |
| 3 | Ventricular tachycardia (HP:0004756) | 6.32644573 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 6.22094310 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 6.01831713 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.80675317 |
| 7 | Myoglobinuria (HP:0002913) | 5.77739608 |
| 8 | Muscle fiber splitting (HP:0003555) | 5.54195265 |
| 9 | Atrial fibrillation (HP:0005110) | 5.44755204 |
| 10 | Primary atrial arrhythmia (HP:0001692) | 5.06897715 |
| 11 | Lipoatrophy (HP:0100578) | 5.04729796 |
| 12 | Abnormality of the calf musculature (HP:0001430) | 5.01808766 |
| 13 | Hyporeflexia of lower limbs (HP:0002600) | 4.94445701 |
| 14 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.92067281 |
| 15 | Subaortic stenosis (HP:0001682) | 4.92067281 |
| 16 | Supraventricular tachycardia (HP:0004755) | 4.90254146 |
| 17 | Supraventricular arrhythmia (HP:0005115) | 4.81020484 |
| 18 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.66624878 |
| 19 | Rhabdomyolysis (HP:0003201) | 4.60035219 |
| 20 | Myopathic facies (HP:0002058) | 4.40642122 |
| 21 | Right ventricular cardiomyopathy (HP:0011663) | 4.38416780 |
| 22 | Syncope (HP:0001279) | 4.30668591 |
| 23 | Dilated cardiomyopathy (HP:0001644) | 4.28054142 |
| 24 | Bundle branch block (HP:0011710) | 4.24925129 |
| 25 | Palpitations (HP:0001962) | 4.18013445 |
| 26 | EMG: myopathic abnormalities (HP:0003458) | 4.00400107 |
| 27 | Asymmetric septal hypertrophy (HP:0001670) | 3.99096275 |
| 28 | Increased connective tissue (HP:0009025) | 3.95810494 |
| 29 | Difficulty running (HP:0009046) | 3.92793557 |
| 30 | Prolonged QT interval (HP:0001657) | 3.92326405 |
| 31 | Ventricular arrhythmia (HP:0004308) | 3.74199611 |
| 32 | Heart block (HP:0012722) | 3.55263790 |
| 33 | Distal arthrogryposis (HP:0005684) | 3.54652313 |
| 34 | Atrioventricular block (HP:0001678) | 3.46184457 |
| 35 | Hepatic necrosis (HP:0002605) | 3.39708052 |
| 36 | Abnormal atrioventricular conduction (HP:0005150) | 3.33607132 |
| 37 | Round ear (HP:0100830) | 3.28124366 |
| 38 | Ventricular fibrillation (HP:0001663) | 3.26566737 |
| 39 | Myotonia (HP:0002486) | 3.25115957 |
| 40 | Ulnar deviation of the wrist (HP:0003049) | 3.22106254 |
| 41 | Hypoglycemic coma (HP:0001325) | 3.17836203 |
| 42 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.06916893 |
| 43 | Distal lower limb amyotrophy (HP:0008944) | 3.05937668 |
| 44 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.01679426 |
| 45 | Type 1 muscle fiber predominance (HP:0003803) | 3.00311042 |
| 46 | Ketoacidosis (HP:0001993) | 2.98845332 |
| 47 | Muscle stiffness (HP:0003552) | 2.96693247 |
| 48 | Difficulty climbing stairs (HP:0003551) | 2.95189384 |
| 49 | Muscle fiber inclusion bodies (HP:0100299) | 2.95156497 |
| 50 | Dicarboxylic aciduria (HP:0003215) | 2.94746395 |
| 51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.94746395 |
| 52 | Acute necrotizing encephalopathy (HP:0006965) | 2.91945843 |
| 53 | Increased muscle lipid content (HP:0009058) | 2.88265305 |
| 54 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.87941651 |
| 55 | Bulbar palsy (HP:0001283) | 2.87203818 |
| 56 | Hepatocellular necrosis (HP:0001404) | 2.81766920 |
| 57 | Frequent falls (HP:0002359) | 2.80487088 |
| 58 | Abnormal EKG (HP:0003115) | 2.80478498 |
| 59 | Left ventricular hypertrophy (HP:0001712) | 2.70125707 |
| 60 | Acute encephalopathy (HP:0006846) | 2.63808055 |
| 61 | Increased variability in muscle fiber diameter (HP:0003557) | 2.54194473 |
| 62 | Neck muscle weakness (HP:0000467) | 2.48810427 |
| 63 | Foot dorsiflexor weakness (HP:0009027) | 2.48768105 |
| 64 | Conjunctival hamartoma (HP:0100780) | 2.46108835 |
| 65 | Cerebral edema (HP:0002181) | 2.45759865 |
| 66 | Ketosis (HP:0001946) | 2.44888268 |
| 67 | Progressive macrocephaly (HP:0004481) | 2.42089728 |
| 68 | Palmoplantar keratoderma (HP:0000982) | 2.40563920 |
| 69 | Mitochondrial inheritance (HP:0001427) | 2.39592880 |
| 70 | Ragged-red muscle fibers (HP:0003200) | 2.38357141 |
| 71 | Distal lower limb muscle weakness (HP:0009053) | 2.37543361 |
| 72 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.37100602 |
| 73 | Areflexia of lower limbs (HP:0002522) | 2.36370038 |
| 74 | Scapular winging (HP:0003691) | 2.35189835 |
| 75 | Increased CSF lactate (HP:0002490) | 2.34114343 |
| 76 | Increased intramyocellular lipid droplets (HP:0012240) | 2.30096639 |
| 77 | Lactic acidosis (HP:0003128) | 2.27050341 |
| 78 | Nemaline bodies (HP:0003798) | 2.26736306 |
| 79 | Hyperglycinuria (HP:0003108) | 2.25705611 |
| 80 | Generalized muscle weakness (HP:0003324) | 2.25631391 |
| 81 | Hyperkalemia (HP:0002153) | 2.24096721 |
| 82 | Calcaneovalgus deformity (HP:0001848) | 2.23586362 |
| 83 | Exercise intolerance (HP:0003546) | 2.23252378 |
| 84 | Abnormality of alanine metabolism (HP:0010916) | 2.22165931 |
| 85 | Hyperalaninemia (HP:0003348) | 2.22165931 |
| 86 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.22165931 |
| 87 | Testicular atrophy (HP:0000029) | 2.16459600 |
| 88 | Waddling gait (HP:0002515) | 2.15900059 |
| 89 | Pheochromocytoma (HP:0002666) | 2.15574619 |
| 90 | Facial diplegia (HP:0001349) | 2.10776325 |
| 91 | Respiratory failure (HP:0002878) | 2.10442233 |
| 92 | Dysmetric saccades (HP:0000641) | 2.10167822 |
| 93 | Lower limb amyotrophy (HP:0007210) | 2.09237681 |
| 94 | Generalized aminoaciduria (HP:0002909) | 2.08427100 |
| 95 | Rimmed vacuoles (HP:0003805) | 2.07096625 |
| 96 | Hamartoma of the eye (HP:0010568) | 2.06145545 |
| 97 | EMG: neuropathic changes (HP:0003445) | 2.04719552 |
| 98 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.04661468 |
| 99 | Abnormality of the endocardium (HP:0004306) | 2.04176170 |
| 100 | Limb-girdle muscle atrophy (HP:0003797) | 2.03681863 |
| 101 | Progressive muscle weakness (HP:0003323) | 2.03071773 |
| 102 | Obstructive sleep apnea (HP:0002870) | 2.00015937 |
| 103 | Weak cry (HP:0001612) | 1.98501709 |
| 104 | Muscular dystrophy (HP:0003560) | 1.96518660 |
| 105 | Hyperammonemia (HP:0001987) | 1.96410533 |
| 106 | Hypoplastic ischia (HP:0003175) | 1.96201331 |
| 107 | Sudden cardiac death (HP:0001645) | 1.94829733 |
| 108 | Gowers sign (HP:0003391) | 1.94793700 |
| 109 | Abnormality of the foot musculature (HP:0001436) | 1.94529020 |
| 110 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.93615760 |
| 111 | Esophageal neoplasm (HP:0100751) | 1.92477078 |
| 112 | Neoplasm of head and neck (HP:0012288) | 1.92477078 |
| 113 | Colitis (HP:0002583) | 1.91777895 |
| 114 | Congestive heart failure (HP:0001635) | 1.91672761 |
| 115 | Neoplasm of the adrenal gland (HP:0100631) | 1.90682611 |
| 116 | Neuroendocrine neoplasm (HP:0100634) | 1.90382138 |
| 117 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.90159785 |
| 118 | Malignant hyperthermia (HP:0002047) | 1.89381853 |
| 119 | Increased serum pyruvate (HP:0003542) | 1.86729891 |
| 120 | Abnormality of glycolysis (HP:0004366) | 1.86729891 |
| 121 | Progressive external ophthalmoplegia (HP:0000590) | 1.85338118 |
| 122 | Deformed tarsal bones (HP:0008119) | 1.84434180 |
| 123 | Absent phalangeal crease (HP:0006109) | 1.82524407 |
| 124 | Easy fatigability (HP:0003388) | 1.81873608 |
| 125 | Hip contracture (HP:0003273) | 1.80565342 |
| 126 | Proximal amyotrophy (HP:0007126) | 1.76205357 |
| 127 | Abnormality of the neuromuscular junction (HP:0003398) | 1.74811561 |
| 128 | Fatigable weakness (HP:0003473) | 1.74811561 |
| 129 | Chest pain (HP:0100749) | 1.69090771 |
| 130 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.62726216 |
| 131 | Steppage gait (HP:0003376) | 1.60903496 |
| 132 | Abnormality of the calcaneus (HP:0008364) | 1.59979121 |
| 133 | Fetal akinesia sequence (HP:0001989) | 1.55720847 |
| 134 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.55681388 |
| 135 | Abnormality of the ischium (HP:0003174) | 1.47762783 |
| 136 | Fatigue (HP:0012378) | 1.46199878 |
| 137 | Eczematoid dermatitis (HP:0000976) | 1.45920982 |
| 138 | Gastrointestinal stroma tumor (HP:0100723) | 1.45505400 |
| 139 | Metaphyseal cupping (HP:0003021) | 1.45453229 |
| 140 | Rapidly progressive (HP:0003678) | 1.41561728 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.31148636 |
| 2 | OBSCN | 4.90685288 |
| 3 | PDK4 | 4.85551700 |
| 4 | PDK3 | 4.85551700 |
| 5 | PHKG2 | 3.71831760 |
| 6 | PHKG1 | 3.71831760 |
| 7 | LMTK2 | 3.33509052 |
| 8 | MYLK | 3.09416098 |
| 9 | PDK2 | 3.04713321 |
| 10 | TRIB3 | 2.89163160 |
| 11 | BCKDK | 2.82923870 |
| 12 | PKN2 | 2.76501366 |
| 13 | DMPK | 2.60164961 |
| 14 | NEK1 | 2.10710495 |
| 15 | TNK2 | 2.07006179 |
| 16 | TIE1 | 1.94483051 |
| 17 | PIK3CA | 1.94407934 |
| 18 | PINK1 | 1.92406260 |
| 19 | MAP4K1 | 1.89464943 |
| 20 | STK24 | 1.82523988 |
| 21 | MUSK | 1.81137739 |
| 22 | BLK | 1.75726948 |
| 23 | MAPK15 | 1.74539226 |
| 24 | ICK | 1.71074739 |
| 25 | MAP3K6 | 1.69842498 |
| 26 | MAP3K13 | 1.57245050 |
| 27 | PRPF4B | 1.50841874 |
| 28 | RIPK4 | 1.30710446 |
| 29 | EEF2K | 1.26770349 |
| 30 | ERN1 | 1.23342374 |
| 31 | WNK4 | 1.22422647 |
| 32 | MAP2K3 | 1.17747297 |
| 33 | PRKD1 | 1.15295182 |
| 34 | GRK7 | 1.14127639 |
| 35 | ZAP70 | 1.11550382 |
| 36 | TBK1 | 1.11227467 |
| 37 | SIK2 | 1.10258539 |
| 38 | ILK | 1.06906468 |
| 39 | MAP3K7 | 1.04609049 |
| 40 | TYK2 | 1.03094014 |
| 41 | PAK3 | 1.03014766 |
| 42 | CAMK2D | 1.01821630 |
| 43 | FGFR4 | 1.00829424 |
| 44 | PRKAA1 | 1.00589200 |
| 45 | PRKAA2 | 0.99513935 |
| 46 | STK38L | 0.98142116 |
| 47 | MAP2K4 | 0.96638283 |
| 48 | MAPK7 | 0.96203703 |
| 49 | ZAK | 0.95758106 |
| 50 | DYRK1B | 0.95087588 |
| 51 | INSRR | 0.91308809 |
| 52 | PRKD3 | 0.91075652 |
| 53 | CSK | 0.89654355 |
| 54 | MAPK12 | 0.89163530 |
| 55 | MAP3K3 | 0.83593098 |
| 56 | MAP3K5 | 0.83131559 |
| 57 | ROCK1 | 0.81605519 |
| 58 | SYK | 0.79159004 |
| 59 | CDC42BPA | 0.78820947 |
| 60 | STK38 | 0.77362154 |
| 61 | IKBKE | 0.76918150 |
| 62 | STK4 | 0.75428441 |
| 63 | RIPK1 | 0.75104890 |
| 64 | KSR2 | 0.74800817 |
| 65 | MAP3K1 | 0.74282975 |
| 66 | TRPM7 | 0.73875363 |
| 67 | FLT3 | 0.73264780 |
| 68 | PTK2B | 0.71331788 |
| 69 | MARK3 | 0.69460873 |
| 70 | BTK | 0.69445725 |
| 71 | MAPKAPK3 | 0.68096068 |
| 72 | PKN1 | 0.67716262 |
| 73 | ITK | 0.66993149 |
| 74 | PRKD2 | 0.66318304 |
| 75 | JAK3 | 0.66083663 |
| 76 | SIK3 | 0.65019831 |
| 77 | STK39 | 0.63295436 |
| 78 | MAPK4 | 0.63271239 |
| 79 | CAMK1D | 0.63052802 |
| 80 | MARK1 | 0.62745267 |
| 81 | WNK1 | 0.59444790 |
| 82 | PDGFRA | 0.59420470 |
| 83 | HCK | 0.59305344 |
| 84 | IRAK4 | 0.58203396 |
| 85 | PDPK1 | 0.57167066 |
| 86 | CAMK4 | 0.56879723 |
| 87 | KIT | 0.56714985 |
| 88 | CSF1R | 0.56713507 |
| 89 | PDK1 | 0.56310372 |
| 90 | FES | 0.55746452 |
| 91 | RPS6KL1 | 0.55163124 |
| 92 | RPS6KC1 | 0.55163124 |
| 93 | MAP3K14 | 0.53868992 |
| 94 | CAMK1G | 0.53341200 |
| 95 | TGFBR2 | 0.53111571 |
| 96 | DAPK3 | 0.53096939 |
| 97 | CDK19 | 0.51249729 |
| 98 | SIK1 | 0.51227435 |
| 99 | STK11 | 0.50032501 |
| 100 | CAMK1 | 0.46450483 |
| 101 | RPS6KA6 | 0.46223195 |
| 102 | KDR | 0.45375622 |
| 103 | GRK6 | 0.45272042 |
| 104 | PTK6 | 0.43175359 |
| 105 | TAOK1 | 0.42699263 |
| 106 | NEK9 | 0.41811283 |
| 107 | JAK2 | 0.41393746 |
| 108 | PRKACB | 0.41277154 |
| 109 | PRKACG | 0.40814408 |
| 110 | CAMK2A | 0.40577683 |
| 111 | BMX | 0.40390028 |
| 112 | EPHB1 | 0.39320463 |
| 113 | ROCK2 | 0.37139966 |
| 114 | FGR | 0.36465806 |
| 115 | MAP2K2 | 0.35120984 |
| 116 | PIK3CG | 0.34314838 |
| 117 | AKT2 | 0.33704067 |
| 118 | PRKACA | 0.33497789 |
| 119 | NME1 | 0.33305807 |
| 120 | MTOR | 0.32063993 |
| 121 | LATS1 | 0.30142420 |
| 122 | RPS6KA1 | 0.28858757 |
| 123 | CAMK2G | 0.27846368 |
| 124 | MAPK11 | 0.27570910 |
| 125 | PRKCE | 0.27558968 |
| 126 | PRKCH | 0.24849287 |
| 127 | SGK3 | 0.21222169 |
| 128 | MAP3K11 | 0.19845203 |
| 129 | FGFR3 | 0.18579001 |
| 130 | EPHB2 | 0.18286578 |
| 131 | RET | 0.16068588 |
| 132 | MARK2 | 0.15708091 |
| 133 | LATS2 | 0.15555552 |
| 134 | PRKG1 | 0.14694840 |
| 135 | TAOK2 | 0.14269989 |
| 136 | JAK1 | 0.13460256 |
| 137 | RPS6KA3 | 0.13116438 |
| 138 | MAP2K6 | 0.12289776 |
| 139 | MAP3K10 | 0.11927892 |
| 140 | SGK1 | 0.11852141 |
| 141 | TESK1 | 0.11638290 |
| 142 | PDGFRB | 0.10384076 |
| 143 | PRKG2 | 0.09652581 |
| 144 | RPS6KA2 | 0.09197886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.45119662 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.38347034 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.09319597 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.78777517 |
| 5 | * Fatty acid degradation_Homo sapiens_hsa00071 | 3.15059810 |
| 6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.13548884 |
| 7 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.09747300 |
| 8 | Carbon metabolism_Homo sapiens_hsa01200 | 2.77425057 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.74783698 |
| 10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.74761980 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.71007234 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.65501784 |
| 13 | * Fatty acid metabolism_Homo sapiens_hsa01212 | 2.55134181 |
| 14 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.33319019 |
| 15 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.05240289 |
| 16 | Alzheimers disease_Homo sapiens_hsa05010 | 2.03065935 |
| 17 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.95575993 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.88589431 |
| 19 | Huntingtons disease_Homo sapiens_hsa05016 | 1.82850490 |
| 20 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.69332490 |
| 21 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.57691695 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.57260199 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.53004821 |
| 24 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 1.48122024 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.47804957 |
| 26 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.46021358 |
| 27 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.43663358 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.43037555 |
| 29 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.30873867 |
| 30 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.28784981 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.27296191 |
| 32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.24240548 |
| 33 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24178500 |
| 34 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.17828801 |
| 35 | Leishmaniasis_Homo sapiens_hsa05140 | 1.12167747 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.09481710 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.05440791 |
| 38 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.03145091 |
| 39 | * Insulin resistance_Homo sapiens_hsa04931 | 1.02365147 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.00152123 |
| 41 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.97539455 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.95043731 |
| 43 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.94887911 |
| 44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.94009929 |
| 45 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.93610823 |
| 46 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.93347818 |
| 47 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91129462 |
| 48 | Lysine degradation_Homo sapiens_hsa00310 | 0.91096297 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.90630108 |
| 50 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.90257785 |
| 51 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86035444 |
| 52 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.83998186 |
| 53 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.83756084 |
| 54 | Long-term potentiation_Homo sapiens_hsa04720 | 0.83524377 |
| 55 | Allograft rejection_Homo sapiens_hsa05330 | 0.80670979 |
| 56 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.80332036 |
| 57 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.79732587 |
| 58 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.79720439 |
| 59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77496008 |
| 60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.76739926 |
| 61 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74254419 |
| 62 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.74122160 |
| 63 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.73616630 |
| 64 | Peroxisome_Homo sapiens_hsa04146 | 0.72661589 |
| 65 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72348231 |
| 66 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.71214507 |
| 67 | Influenza A_Homo sapiens_hsa05164 | 0.69171335 |
| 68 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.68757880 |
| 69 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.66762936 |
| 70 | Tuberculosis_Homo sapiens_hsa05152 | 0.66740650 |
| 71 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.66189518 |
| 72 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.64571026 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64437630 |
| 74 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63984111 |
| 75 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.62578955 |
| 76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62209897 |
| 77 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60372641 |
| 78 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.59960902 |
| 79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59617428 |
| 80 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59267297 |
| 81 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.57393372 |
| 82 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.56912035 |
| 83 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56246642 |
| 84 | Focal adhesion_Homo sapiens_hsa04510 | 0.56124497 |
| 85 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.55917089 |
| 86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55509738 |
| 87 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55202356 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55200820 |
| 89 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.55143989 |
| 90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54802833 |
| 91 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50682926 |
| 92 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.49701483 |
| 93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49254682 |
| 94 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.48948354 |
| 95 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48441987 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47771266 |
| 97 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.47738839 |
| 98 | Measles_Homo sapiens_hsa05162 | 0.47318793 |
| 99 | Renin secretion_Homo sapiens_hsa04924 | 0.46511751 |
| 100 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45417678 |
| 101 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.45365138 |
| 102 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.45048549 |
| 103 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.44001233 |
| 104 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.43646743 |
| 105 | Tight junction_Homo sapiens_hsa04530 | 0.43452997 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | 0.43395435 |
| 107 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.41853265 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.41061454 |
| 109 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.38035798 |
| 110 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.34546162 |
| 111 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.31652011 |
| 112 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.30982570 |
| 113 | Metabolic pathways_Homo sapiens_hsa01100 | 0.30698710 |
| 114 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.28289053 |
| 115 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.27793488 |
| 116 | Adherens junction_Homo sapiens_hsa04520 | 0.25924129 |
| 117 | Circadian rhythm_Homo sapiens_hsa04710 | 0.24577103 |
| 118 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.24224172 |
| 119 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.23797747 |
| 120 | Insulin secretion_Homo sapiens_hsa04911 | 0.20698121 |
| 121 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.20412602 |
| 122 | Amoebiasis_Homo sapiens_hsa05146 | 0.18230923 |
| 123 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.16107274 |
| 124 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.15925560 |
| 125 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.13417423 |
| 126 | Bile secretion_Homo sapiens_hsa04976 | 0.09657761 |
| 127 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.09334547 |
| 128 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.07842030 |
| 129 | ABC transporters_Homo sapiens_hsa02010 | 0.07324745 |
| 130 | Circadian entrainment_Homo sapiens_hsa04713 | 0.07059989 |
| 131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.06906772 |
| 132 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.06291102 |
| 133 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.05653553 |
| 134 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.05598757 |
| 135 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.05184171 |
| 136 | Platelet activation_Homo sapiens_hsa04611 | 0.03857071 |
| 137 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.03349848 |
| 138 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.02623757 |
| 139 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.01405552 |
| 140 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.01048209 |
| 141 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.00382460 |
| 142 | Small cell lung cancer_Homo sapiens_hsa05222 | -0.0396098 |
| 143 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0337786 |
| 144 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0214217 |
| 145 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0145201 |
| 146 | GnRH signaling pathway_Homo sapiens_hsa04912 | -0.0128326 |

